Your browser doesn't support javascript.
loading
Sacral nerve stimulation for constipation: long-term outcomes.
Gortazar de Las Casas, S; Rubio-Pérez, I; Saavedra Ambrosy, J; Sancho de Avila, A; Álvarez-Gallego, M; Marijuan Martín, J L; Pascual Miguelañez, I.
Afiliación
  • Gortazar de Las Casas S; Department of Surgery, La Paz University Hospital, Madrid, Spain. saragortazar@gmail.com.
  • Rubio-Pérez I; Department of Surgery, La Paz University Hospital, Madrid, Spain.
  • Saavedra Ambrosy J; Department of Surgery, La Paz University Hospital, Madrid, Spain.
  • Sancho de Avila A; Department of Anaesthesiology and Intensive Care, La Paz University Hospital, Madrid, Spain.
  • Álvarez-Gallego M; Department of Surgery, La Paz University Hospital, Madrid, Spain.
  • Marijuan Martín JL; Department of Surgery, La Paz University Hospital, Madrid, Spain.
  • Pascual Miguelañez I; Department of Surgery, La Paz University Hospital, Madrid, Spain.
Tech Coloproctol ; 23(6): 559-564, 2019 Jun.
Article en En | MEDLINE | ID: mdl-31147802
ABSTRACT

BACKGROUND:

There has been some controversy regarding the efficacy of sacral nerve stimulation (SNS) for the treatment of chronic constipation, due to less positive outcomes and concerns about cost-effectiveness in the long term. The aim of the present study was to evaluate the long-term outcomes of SNS in patients with chronic constipation.

METHODS:

A retrospective study was conducted on patients who had SNS for chronic constipation in 2008-2017 at our institution. Clinical factors, profile of constipation, physiology studies, and patient satisfaction with SNS therapy were investigated during a follow-up period up to 10 years after the implantation.

RESULTS:

Twenty-nine patients [86% female, median age 49 years (range 17-86)] were tested for SNS, and 24 received implants after a positive test phase [median 47 days (range 21-56 days)]. There were 27 bilateral and 2 unilateral implants, in S3 or S4 depending on best response. Mean follow-up was 59 months. Efficacy was considered as a score > 5 (on a scale of 1-10) in general symptom improvement. Nine (37.9%) implanted patients had a satisfaction score > 5. In 6 cases (25%), patient satisfaction was higher than 9. Due to the small sample size, there were no statistically significant variables considered as predictors of response.

CONCLUSIONS:

Our results agree with current studies which describe around a 30% response of SNS for refractory constipation. However, there is a small group of patients highly satisfied with SNS therapy. More studies are needed to better understand this profile and optimize outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sacro / Factores de Tiempo / Terapia por Estimulación Eléctrica / Satisfacción del Paciente / Estreñimiento Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies Aspecto: Patient_preference Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Tech Coloproctol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sacro / Factores de Tiempo / Terapia por Estimulación Eléctrica / Satisfacción del Paciente / Estreñimiento Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies Aspecto: Patient_preference Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Tech Coloproctol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: España